Regulatory & Legal

A strategic investment firm's move signals strong confidence in the closing of Avadel's multi-billion dollar deal, spotlighting its blockbuster sleep drug.

As Australia's new social media age-gate law takes effect, privacy-conscious adults are turning to VPNs to avoid sharing sensitive data with tech giants.

A new Space Force contract for real-time data processing aims to achieve "decision superiority" in an increasingly contested and dangerous orbital domain.

A 1.26% stake in Just Group, held via derivatives by Balyasny, reveals a classic merger arbitrage strategy as Brookfield's £2.4bn acquisition nears.

J.P. Morgan's 2026 outlook reveals how private markets, fueled by AI, are rebuilding the physical backbone of the global supply chain.

A new oral drug could eliminate the dangerous side effects of CAR T-Cell therapy, potentially making the breakthrough cancer treatment safer and more accessible.

Stunning trial data reveals an immunotherapy combo that slashes myeloma progression by 83%, offering not just longer life but a better quality of life.

In post-acute care, is training enough? A new digital platform aims to verify caregiver skills at the bedside, tackling both compliance and care quality.

Domestic manufacturing, massive power demands from AI and EVs, and a skilled labor shortage are converging to define a pivotal year for American industry.

With a $12M boost from a16z, Pryzm's AI is tackling the Pentagon's $900B procurement problem. Can software fix bureaucracy and secure America's edge?

Cohere Health's new Policy Studio uses AI to digitize archaic medical policies, promising to cut costs, ease provider burden, and meet new regulations.

A Texas vehicle maker is deploying its Bitcoin into regulated DeFi. Is this a risky gamble or the new blueprint for corporate finance innovation?

Secure identity firm CLEAR lands a major CMS contract to overhaul Medicare.gov's login system, signaling a strategic push into the government sector.

A family-owned store's record safe sales reveal a story of niche retail, tax incentives, and a parent company's ambitious 'patriotic lifestyle' gamble.

A famed NYC pub's arrival signals a new era for Atlanta's downtown, as the massive Centennial Yards project races to redefine the city for a global stage.

As 4G fades and full 5G remains costly, a new technology offers a balanced solution, making advanced, secure connectivity a reality for every driver.

Law firm Gunderson Dettmer's major partner expansion signals confidence not in the whole market, but in the AI-driven, high-value core of the venture economy.

A new narcolepsy drug could finally offer patients what they've been missing: a single nightly dose with low sodium, transforming lives and the market.

Celldex is launching a pivotal Phase 3 trial for a drug that could be the first advanced therapy for two debilitating and untreated chronic hive conditions.

Century Therapeutics adds M&A and investment heavyweights to its board, a strategic move to navigate the clinical gauntlet with its iPSC-derived diabetes cure.